In part 4 of this 6part CMECEcertified Medical Minute series we differentiate LAI antipsychotic properties based on formulation dosing strategies and administration We dive into the pharmacology and characteristics of LAI APs available in the market and discuss dosing frequency oral overlap and administration requirements
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/neurology/lai-mm4-2024/25076-48170
- Start Date: 2024-08-21 05:00:00
- End Date: 2024-08-21 05:00:00
- Credit Details: IPCE Credits: 0.25 hours
AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Indivior Inc - Amount: 2272.72 - Is Kind Support: False Source: Otsuka America Pharmaceutical, Inc. - Amount: 4545.45 - Is Kind Support: False Source: Teva Pharmaceutical Industries - Amount: 22727.27 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest